Navigation Links
Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
Date:1/8/2009

Public Health Physician Spent Last 10 Years Helping Implement World Bank HIV/AIDS and Malaria Initiatives

CAMBRIDGE, Mass., Jan. 8 /PRNewswire/ -- Abt Associates announced that Dr. John Osika has joined the company as a Principal Associate and HIV/AIDS and Infectious Disease Advisor. Dr. Osika, a board certified physician in the United Kingdom and European Union, is a recognized public health expert with extensive experience working on HIV/AIDS and infectious disease programs.

Over his 21 year professional career he has provided technical leadership to the World Bank's landmark Roll Back Malaria initiative and served as the Bank's principal source of technical advice and leadership on malaria programs and policy. Since 2000, he has used his infectious disease expertise and public health technical skills to provide leadership to World Bank HIV/AIDS programs throughout the world. During this time Dr. Osika has earned a stellar reputation as a technical leader and highly effective source of technical and policy support to World Bank-funded HIV/AIDS programs, including programs being implemented under extremely difficult circumstances. Prior to working for the World Bank, Dr. Osika served as Assistant Professor in Public Health Medicine at the University of Wales and as Registrar in Public Health Medicine for the British National Health Service.

"John combines recognized technical and clinical qualifications with the experience of working with the highest level policy makers on HIV/AIDS and infectious disease in the countries most afflicted by these epidemics," said Nancy Pielemeier, Division Vice President for Health Systems and Infectious Diseases. "We are delighted to have someone of his capability join our HIV/AIDS and Infectious Disease team."

Dr. Osika received his M.D. from Minsk State Medical University, Belarus; a Master of Public Health degree from the University of Leeds, England; and a Master of Health Management and Planning degree from the University of Leeds. He is a Fellow of the Faculty of Public Health of the Royal Colleges of Physicians, United Kingdom.

Abt Associates applies scientific research, technical assistance and consulting expertise to a wide range of social, economic and health policy issues; international development; clinical trials and registries; and complex business problems. Founded in 1965, the company provides services to U.S. federal, state and local governments; universities and foundations; media; and major corporations. Its staff of over 1,000 is located in Cambridge, Massachusetts; Atlanta, Georgia; Bethesda, Maryland; Durham, North Carolina; Lexington, Massachusetts (Abt Bio-Pharma Solutions, Inc.); New York, New York (Abt SRBI); and in Africa, Asia, Central Asia, Europe, Latin America, and the Middle East.


'/>"/>
SOURCE Abt Associates
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Immunosyn Announces Interview of CEO Stephen D. Ferrone by CEOCFO Interviews & News
2. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
3. US Oncology Appoints Stephen Smith Vice President/General Manager Research and Personalized Science Services
4. Neurofocus Appoints Stephen Kosslyn to Its Advisory Board
5. Genomic Health to Present at Stephens Fall Investment Conference
6. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
7. Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
8. Advanced Life Sciences to Present Data from Selected Cethromycin Clinical Trials at the 45th Annual Meeting of the Infectious Diseases Society of America
9. Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
10. Specialists in infectious disease and global health convene at Philadelphia meeting
11. Collaborative Software Initiative Addresses State Governments Requirements for Meeting Infectious Disease Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... Baltimore ... of the Maryland Biohealth community in developing and issuing recommendations to grow Maryland's ... BioHealth Innovation Hub by 2023. , The recommendations are contained ...
(Date:5/19/2017)... Philadelphia, PA (PRWEB) , ... May 19, 2017 ... ... for its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, ... Pennsylvania, New Jersey and Delaware, are encouraged to submit proposals. QED, now in ...
(Date:5/18/2017)... (PRWEB) , ... May 17, ... ... CRO standards with psychonneuroendocrine stress expertise, and further enhances its scientific power ... researcher, Douglas A. Granger, Ph.D., has agreed to join the scientific advisory ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... are more likely to develop Alzheimer’s disease, while men are at greater risk ... this gender-specific neuronal bias is the aim of a research program at Worcester ...
Breaking Biology Technology:
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):